help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on January 26, 2006, doi:10.1164/rccm.200511-1797PP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200511-1797PPv1
173/10/1072    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lomas, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lomas, D. A.
American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 1072-1077, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200511-1797PP

Pulmonary Perspective

The Selective Advantage of {alpha}1-Antitrypsin Deficiency

David A. Lomas

Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom

Correspondence and requests for reprints should be addressed to Prof. David Lomas, Sc.D., F.R.C.P., Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 2XY UK. E-mail: dal16{at}cam.ac.uk

ABSTRACT

The S- and Z-deficiency alleles of {alpha}1-antitrypsin are found in more than 20% of some white populations. This high gene frequency suggests that these mutations confer a selective advantage, but the biologic mechanism of this has remained obscure. It is now well recognized that the S and Z alleles result in a conformational transition within the {alpha}1-antitrypsin molecule and the formation of polymers that are retained within the endoplasmic reticulum of hepatocytes. Polymers of mutant {alpha}1-antitrypsin can also form within the alveoli and small airways of the lung where they may drive the inflammation that underlies emphysema in individuals with {alpha}1-antitrypsin deficiency. This local production of polymers by mutant S and Z {alpha}1-antitrypsin may have also provided protection against infectious disease in the preantibiotic era by focusing and amplifying the inflammatory response to limit invasive respiratory and gastrointestinal infection. It is only since the discovery of antibiotics, the widespread adoption of smoking, and increased longevity that these protective, proinflammatory properties of {alpha}1-antitrypsin mutants have become detrimental to cause the emphysema and systemic inflammatory diseases associated with {alpha}1-antitrypsin deficiency.

Key Words: {alpha}1-antitrypsin • inflammation • polymers • serpinopathies • serpins




This article has been cited by other articles:


Home page
 JEMHome page
B. Gooptu and D. A. Lomas
Polymers and inflammation: disease mechanisms of the serpinopathies
J. Exp. Med., July 7, 2008; 205(7): 1529 - 1534.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
C. P. Hersh, D. L. DeMeo, and E. K. Silverman
National Emphysema Treatment Trial State of the Art: Genetics of Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. K. Hogarth and G. Rachelefsky
Screening and Familial Testing of Patients for {alpha}1-Antitrypsin Deficiency
Chest, April 1, 2008; 133(4): 981 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri
Update in Chronic Obstructive Pulmonary Disease 2006
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society 		  ATS Clinical Skills Tests